Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Cash & Current Investments (2018 - 2026)

Alector's (ALEC) quarterly Cash & Current Investments came in at $172.8 million in Q2 2026, down 43.77% year-over-year from $307.3 million in Q2 2025, and down 16.33% quarter-over-quarter from $206.5 million in Q1 2026.

Analysis

Alector (ALEC) Cash & Current Investments (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Cash & Current Investments for 9 consecutive years, with $172.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash & Current Investments fell 43.77% year-over-year to $172.8 million in Q2 2026; TTM through Jun 2026 was $172.8 million, a 43.77% decrease from a year earlier, with the FY2025 full-year figure at $256.0 million, down 38.07% from the prior year.
  • Cash & Current Investments was $172.8 million for Q2 2026 at Alector, down from $206.5 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $868.6 million in Q1 2022 and troughed at $172.8 million in Q2 2026.
  • A 5-year average of $506.1 million and a median of $526.1 million in 2023 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments jumped 153.11% in 2022 and sank 43.77% in 2026, its largest moves.
  • Over 5 years, Cash & Current Investments stood at $712.9 million in 2022, then decreased by 23.0% to $548.9 million in 2023, then declined by 24.68% to $413.4 million in 2024, then slumped by 38.07% to $256.0 million in 2025, then sank by 32.51% to $172.8 million in 2026.
  • The last three Cash & Current Investments figures came in at $172.8 million (Q2 2026), $206.5 million (Q1 2026), and $256.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 13.99 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 3.18 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 7.85 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 7.99 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 5.18 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 5.14 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 3.31 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 1.29 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 1.16 Bn
10 Alector 274.68 Mn 101.88 Mn - 172.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 172.80 Mn
Mar 31, 2026 206.52 Mn
Dec 31, 2025 256.02 Mn
Sep 30, 2025 291.11 Mn
Jun 30, 2025 307.28 Mn
Mar 31, 2025 354.55 Mn
Dec 31, 2024 413.40 Mn
Sep 30, 2024 457.20 Mn
Jun 30, 2024 503.33 Mn
Mar 31, 2024 562.08 Mn
Dec 31, 2023 548.86 Mn
Sep 30, 2023 588.86 Mn
Jun 30, 2023 630.05 Mn
Mar 31, 2023 669.33 Mn
Dec 31, 2022 712.85 Mn
Sep 30, 2022 758.31 Mn
Jun 30, 2022 808.86 Mn
Mar 31, 2022 868.57 Mn
Dec 31, 2021 735.25 Mn
Sep 30, 2021 777.85 Mn